23 Nov 2006

CHMP Adopts Positive Opinion Recommending Approval of Keppra® as Adjunctive Therapy in the Treatment of Primary Generalised Tonic-Clonic Seizures

Read More
21 Nov 2006

UCB OBTAINS EUROPEAN ANTITRUST CLEARANCE FOR TAKE-OVER OF SCHWARZ PHARMA

Read More
10 Nov 2006

UCB ANNOUNCES COMMENCEMENT OF ACCEPTANCE PERIOD FOR TAKEOVER OF SCHWARZ PHARMA

Read More
7 Nov 2006

UCB EXPANDS TO CANADA

Read More
23 Oct 2006

New Analysis Shows CIMZIA(TM) (Certolizumab Pegol) Maintained Remission and Response in Recent Onset Crohn's Disease

Read More
23 Oct 2006

New Efficacy Data Show CIMZIA(TM) (Certolizumab Pegol) Maintained Response and Remission in Crohn's Patients Previously Treated With Infliximab

Read More
23 Oct 2006

UCB Extraordinary Shareholders' General Meeting Approved Capital Increase

Read More
3 Oct 2006

UCB and Jazz Pharmaceuticals announce expansion of Xyrem® license agreement to include fibromyalgia syndrome

Read More
2 Oct 2006

UCB and Biogen Idec to Collaborate on Oral Multiple Sclerosis Therapy

Read More
26 Sep 2006

UCB hosts its first Research and Development Day

Read More
Subscribe to